These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 35490953)

  • 1. Effects of 25-hydroxy vitamin D on T lymphocyte subsets and sputum smear conversion during antituberculosis treatment.
    Yang H; Chen H; Ma Y; Dong Z; Ni M; Lin Y; Zhang L; Zhou D; Zhang Q
    Int J Infect Dis; 2022 Aug; 121():17-23. PubMed ID: 35490953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotype-independent association between profound vitamin D deficiency and delayed sputum smear conversion in pulmonary tuberculosis.
    Junaid K; Rehman A; Saeed T; Jolliffe DA; Wood K; Martineau AR
    BMC Infect Dis; 2015 Jul; 15():275. PubMed ID: 26193879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of vitamin D supplementation on the outcome of pulmonary tuberculosis treatment in adults: a meta-analysis of randomized controlled trials.
    Zhang J; Chen C; Yang J
    Chin Med J (Engl); 2019 Dec; 132(24):2950-2959. PubMed ID: 31833904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk and outcome of multidrug-resistant tuberculosis: vitamin D receptor polymorphisms and serum 25(OH)D.
    Rathored J; Sharma SK; Singh B; Banavaliker JN; Sreenivas V; Srivastava AK; Mohan A; Sachan A; Harinarayan CV; Goswami R
    Int J Tuberc Lung Dis; 2012 Nov; 16(11):1522-8. PubMed ID: 22990231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of vitamin D supplementation on the outcomes of patients with pulmonary tuberculosis: a systematic review and meta-analysis.
    Wu HX; Xiong XF; Zhu M; Wei J; Zhuo KQ; Cheng DY
    BMC Pulm Med; 2018 Jun; 18(1):108. PubMed ID: 29954353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between 25-hydroxyvitamin D levels and treatment course of pulmonary tuberculosis.
    Sato S; Tanino Y; Saito J; Nikaido T; Inokoshi Y; Fukuhara A; Fukuhara N; Wang X; Ishida T; Munakata M
    Respir Investig; 2012 Jun; 50(2):40-5. PubMed ID: 22749249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjunctive vitamin D in tuberculosis treatment: meta-analysis of individual participant data.
    Jolliffe DA; Ganmaa D; Wejse C; Raqib R; Haq MA; Salahuddin N; Daley PK; Ralph AP; Ziegler TR; Martineau AR
    Eur Respir J; 2019 Mar; 53(3):. PubMed ID: 30728208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher serum 25-hydroxyvitamin D concentrations are associated with active pulmonary tuberculosis in hospitalised HIV infected patients in a low income tropical setting: a cross sectional study.
    Musarurwa C; Zijenah LS; Mhandire DZ; Bandason T; Mhandire K; Chipiti MM; Munjoma MW; Mujaji WB
    BMC Pulm Med; 2018 May; 18(1):67. PubMed ID: 29739378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alcohol drinking delays the rate of sputum smear conversion among DR-TB patients in northwest Ethiopia; A retrospective follow-up study.
    Merid MW; Muluneh AG; Kassa GM
    PLoS One; 2022; 17(3):e0264852. PubMed ID: 35263367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial.
    Wejse C; Gomes VF; Rabna P; Gustafson P; Aaby P; Lisse IM; Andersen PL; Glerup H; Sodemann M
    Am J Respir Crit Care Med; 2009 May; 179(9):843-50. PubMed ID: 19179490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjunctive vitamin A and D during pulmonary tuberculosis treatment: a randomized controlled trial with a 2 × 2 factorial design.
    Wang J; Xiong K; Wang Q; Zhao S; Liu Y; Ma A
    Food Funct; 2020 May; 11(5):4672-4681. PubMed ID: 32406431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of high serum vitamin D concentrations with active pulmonary TB in an HIV co-endemic setting, Harare, Zimbabwe.
    Musarurwa C; Zijenah LS; Duri DZ; Mateveke-Dangaiso K; Mhandire K; Chipiti MM; Munjoma MW; Mujaji WB
    BMC Infect Dis; 2017 Feb; 17(1):142. PubMed ID: 28193202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Culture conversion rate at 2 months of treatment according to diagnostic methods among patients with culture-positive pulmonary tuberculosis.
    Lee HY; Chae KO; Lee CH; Choi SM; Lee J; Park YS; Lee SM; Yoo CG; Kim YW; Han SK; Yim JJ
    PLoS One; 2014; 9(8):e103768. PubMed ID: 25105410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zinc and vitamin A supplementation fails to reduce sputum conversion time in severely malnourished pulmonary tuberculosis patients in Indonesia.
    Pakasi TA; Karyadi E; Suratih NM; Salean M; Darmawidjaja N; Bor H; van der Velden K; Dolmans WM; van der Meer JW
    Nutr J; 2010 Sep; 9():41. PubMed ID: 20920186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased IL-17 during treatment of sputum smear-positive pulmonary tuberculosis due to increased regulatory T cells and IL-10.
    Xu L; Cui G; Jia H; Zhu Y; Ding Y; Chen J; Lu C; Ye P; Gao H; Li L; Ma W; Lyu J; Diao H
    J Transl Med; 2016 Jun; 14(1):179. PubMed ID: 27311307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial.
    Martineau AR; Timms PM; Bothamley GH; Hanifa Y; Islam K; Claxton AP; Packe GE; Moore-Gillon JC; Darmalingam M; Davidson RN; Milburn HJ; Baker LV; Barker RD; Woodward NJ; Venton TR; Barnes KE; Mullett CJ; Coussens AK; Rutterford CM; Mein CA; Davies GR; Wilkinson RJ; Nikolayevskyy V; Drobniewski FA; Eldridge SM; Griffiths CJ
    Lancet; 2011 Jan; 377(9761):242-50. PubMed ID: 21215445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baseline Xpert MTB/RIF ct values predict sputum conversion during the intensive phase of anti-TB treatment in HIV infected patients in Kampala, Uganda: a retrospective study.
    Namugenyi J; Musaazi J; Katamba A; Kalyango J; Sendaula E; Kambugu A; Fehr J; Castelnouvo B; Manabe YC; Ssengooba W; Sekaggya-Wiltshire C
    BMC Infect Dis; 2021 Jun; 21(1):513. PubMed ID: 34074248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting results of mycobacterial culture on sputum smear reversion after anti-tuberculous treatment: a case control study.
    Shu CC; Wang JT; Lee CH; Wang JY; Lee LN; Yu CJ
    BMC Infect Dis; 2010 Mar; 10():48. PubMed ID: 20205743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic effects of recombinant human interleukin 2 as adjunctive immunotherapy against tuberculosis: A systematic review and meta-analysis.
    Zhang R; Xi X; Wang C; Pan Y; Ge C; Zhang L; Zhang S; Liu H
    PLoS One; 2018; 13(7):e0201025. PubMed ID: 30024982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sputum smear conversion and associated factors among smear-positive pulmonary tuberculosis patients in East Gojjam Zone, Northwest Ethiopia: a longitudinal study.
    Asemahagn MA
    BMC Pulm Med; 2021 Apr; 21(1):118. PubMed ID: 33832466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.